TY  - GEN
AU  - Choi,Woonyoung
AU  - Porten,Sima
AU  - Kim,Seungchan
AU  - Willis,Daniel
AU  - Plimack,Elizabeth R
AU  - Hoffman-Censits,Jean
AU  - Roth,Beat
AU  - Cheng,Tiewei
AU  - Tran,Mai
AU  - Lee,I-Ling
AU  - Melquist,Jonathan
AU  - Bondaruk,Jolanta
AU  - Majewski,Tadeusz
AU  - Zhang,Shizhen
AU  - Pretzsch,Shanna
AU  - Baggerly,Keith
AU  - Siefker-Radtke,Arlene
AU  - Czerniak,Bogdan
AU  - Dinney,Colin P N
AU  - McConkey,David J
TI  - Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy
SN  - 1878-3686
PY  - 2014///0408
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Blotting, Western
KW  - Carcinoma, Basal Cell
KW  - drug therapy
KW  - Carcinoma, Squamous Cell
KW  - Cell Differentiation
KW  - Cell Proliferation
KW  - Cisplatin
KW  - administration & dosage
KW  - Clinical Trials, Phase II as Topic
KW  - Cohort Studies
KW  - Doxorubicin
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Profiling
KW  - Humans
KW  - Male
KW  - Methotrexate
KW  - MicroRNAs
KW  - Muscle Neoplasms
KW  - classification
KW  - Mutation
KW  - Neoadjuvant Therapy
KW  - Neoplasm Invasiveness
KW  - Neoplasm Staging
KW  - PPAR gamma
KW  - Prognosis
KW  - RNA, Messenger
KW  - Real-Time Polymerase Chain Reaction
KW  - Receptor, Fibroblast Growth Factor, Type 3
KW  - Receptors, Estrogen
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Tumor Suppressor Protein p53
KW  - Urinary Bladder Neoplasms
KW  - Vinblastine
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ccr.2014.01.009
ER  -